The Diagnostic Utility of Ultrasound in Pelvic Inflammatory Disease (PID)
1 other identifier
observational
139
1 country
1
Brief Summary
Pelvic inflammatory disease (PID) represents a significant and complex health issue affecting women, particularly those of reproductive age. Characterized by the infection and inflammation of the reproductive organs, PID often results from ascending infections primarily caused by sexually transmitted pathogens, such as Neisseria gonorrhoeae and Chlamydia trachomation. However, it can also be associated with endogenous bacteria or occur following surgical procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 26, 2024
CompletedFirst Posted
Study publicly available on registry
January 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 16, 2025
CompletedJanuary 3, 2025
December 1, 2024
4 months
December 26, 2024
December 26, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
ultrasound
Ultrasound (GE Logiq P7 convex probe.3.5-5MHz) imaging using a curvilinear transducer that provides a broad field of view, commonly used for evaluating abdominal and pelvic organs. Doppler flow characteristics which increased blood flow in the pelvic region, especially around the fallopian tubes or ovaries, as detected by color Doppler ultrasound, indicative of inflammation.
12 Months
Interventions
Early and accurate diagnosis using ultrasound minimizes delays in treatment initiation, thereby preventing complications such as chronic pain and abscess formation. By reducing the severity and duration of the disease, ultrasound contributes to improved patient well-being and a quicker recovery trajectory.
Eligibility Criteria
to check the Pelvic Inflammatory Disease (PID) using Ultrasound
You may qualify if:
- Women of reproductive age (18-45 years) presenting with symptoms suggestive of pelvic inflammatory disease (PID).
- Patients who have been clinically diagnosed with PID based on symptoms such as lower abdominal pain, fever, abnormal vaginal discharge, and tenderness upon pelvic examination.
- Patients who have undergone preliminary diagnostic tests, such as high vaginal swab (HVS) and urine microscopy, culture, and sensitivity (m/c/s), prior to ultrasound assessment.
You may not qualify if:
- Pregnant women, due to potential confounding factors in ultrasound findings and differential diagnosis.
- Patients with chronic pelvic pain not related to acute PID episodes.
- Patients who do not provide informed consent for participation in the study.
- Patients with a history of recent pelvic surgery within the last 6 months, as postoperative changes may affect ultrasound findings.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lady Reading Hospital
Peshawar, Khyber Pakhtunkhwa, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 26, 2024
First Posted
January 3, 2025
Study Start
February 18, 2024
Primary Completion
July 1, 2024
Study Completion
February 16, 2025
Last Updated
January 3, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share